Antiviral Traditional Medicine Market

Anti-viral traditional Chinese medicine mainly includes anti-HIV, anti-CVB, anti-HBV, anti-influenza virus, anti-herpes virus traditional Chinese medicine. At present, the COVID-19c epidemic is progressing rapidly, and Chinese medicine has a long history. It plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results.
Antiviral Traditional Medicine Market contains market size and forecasts of Antiviral Traditional Chinese Medicine in Global, including the following market information:
Global Antiviral Traditional Chinese Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antiviral Traditional Chinese Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-HIV Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiviral Traditional Chinese Medicine include Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical and Green Valley Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiviral Traditional Chinese Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Traditional Chinese Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antiviral Traditional Chinese Medicine Market Segment Percentages, by Type, 2021 (%)
Anti-HIV
Anti-CVB
Anti-HBV
Anti-influenza Virus
Anti-herpes Virus
Other
Global Antiviral Traditional Chinese Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antiviral Traditional Chinese Medicine Market Segment Percentages, by Application, 2021 (%)
Adult
Children
Global Antiviral Traditional Chinese Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antiviral Traditional Chinese Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiviral Traditional Chinese Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antiviral Traditional Chinese Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Guangzhou Pharmaceutical
CR SANJIU
TASLY
China TCM
Yunnan Baiyao
Tongrentang
Jumpcan
Zhejiang Conba Pharmaceutical
Green Valley Pharma
Changbaishan Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Gerun Pharmaceutical
Shineway Pharmaceutical
Yiling Pharmaceutical
Harbin Pharmaceutical Group